Intellia Therapeutics, Inc. (NTLA)
12.64
-0.40
(-3.07%)
USD |
NASDAQ |
Feb 20, 16:00
12.68
+0.04
(+0.32%)
After-Hours: 20:00
Intellia Therapeutics SG&A Expense (Quarterly) : 30.51M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 26.74M |
| Personalis, Inc. | 13.03M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Pacific Biosciences of California, Inc. | 34.05M |
| Twist Bioscience Corp. | 69.74M |